ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,769.00
0.41%
S&P ASX All Technology
3,068.30
0.93%
Brent Oil
77.655
0.71%
US Dollar vs AUD
1.50126
-0.23%
Bitcoin
71,091.90
0.66%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Olema Pharmaceuticals Inc (OLMA)

  7. Olema Pharmaceuticals Inc (OLMA) News

OLMA Olema Pharmaceuticals Inc

13.99
0.00 (0.00%)
Pre Market
Last Updated: 18:02:34
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 13.99 18:02:34
Open Price Low Price High Price Close Price Previous Close
13.99
more quote information »

Recent News

Date Time Source Heading
05/6/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202406:28GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
05/6/202405:09EDGAR2Form 144 - Report of proposed sale of securities
04/6/202404:55EDGAR2Form 144 - Report of proposed sale of securities
01/6/202402:17EDGAR2Form 144 - Report of proposed sale of securities
29/5/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202421:03GLOBEOlema Oncology to Participate in Upcoming Investor..
15/5/202421:06EDGAR2Form 8-K - Current report
15/5/202421:01GLOBEOlema Oncology Announces Promising New Data for Palazestrant..
09/5/202406:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202406:06EDGAR2Form 8-K - Current report
09/5/202406:02GLOBEOlema Oncology Reports First Quarter 2024 Financial Results..
08/5/202421:02GLOBEOlema Oncology Announces New Clinical Data for Palazestrant..
08/5/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202406:00EDGAR2Form 144 - Report of proposed sale of securities
03/5/202406:37GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01/5/202421:02GLOBEOlema Oncology to Participate in Upcoming Investor..
09/4/202406:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
03/4/202407:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
12/3/202407:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/3/202407:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/3/202407:05EDGAR2Form 8-K - Current report
12/3/202407:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
06/3/202423:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
05/3/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01/3/202406:26EDGAR2Form 144 - Report of proposed sale of securities
15/2/202408:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202404:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202409:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
06/2/202423:01GLOBEOlema Oncology to Participate in Upcoming Investor..
06/2/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
02/2/202407:24EDGAR2Form 144 - Report of proposed sale of securities
01/2/202408:21EDGAR2Form S-3 - Registration statement under Securities Act of..
01/2/202406:58EDGAR2Form 144 - Report of proposed sale of securities
29/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202401:07EDGAR2Form 8-K - Current report
09/1/202400:18EDGAR2Form 8-K - Current report
09/1/202400:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
06/1/202409:26EDGAR2Form 8-K - Current report
06/1/202409:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:01GLOBEOlema Oncology to Present at 42nd Annual J.P. Morgan..
30/12/202307:54EDGAR2Form 144 - Report of proposed sale of securities
19/12/202310:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
OLMA
Olema Pharmaceuticals
COIN
FITNGBP
300FIT Network
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved